HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jingyi Tang Selected Research

Inflammation (Inflammations)

4/2023Effects of hypoxia-inducible factor prolyl hydroxylase inhibitors versus erythropoiesis-stimulating agents on iron metabolism and inflammation in patients undergoing dialysis: A systematic review and meta-analysis.
1/2023Identification of biomarkers related to immune and inflammation in membranous nephropathy: comprehensive bioinformatic analysis and validation.
1/2023From Diabetic Nephropathy to End-Stage Renal Disease: The Effect of Chemokines on the Immune System.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jingyi Tang Research Topics

Disease

12Neoplasms (Cancer)
04/2024 - 01/2021
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 01/2022
3Malaria
10/2023 - 11/2020
3Inflammation (Inflammations)
04/2023 - 01/2023
3Membranous Glomerulonephritis (Membranous Nephropathy)
01/2023 - 01/2021
3Lung Neoplasms (Lung Cancer)
01/2023 - 01/2022
3Chronic Kidney Failure (Chronic Renal Failure)
01/2023 - 01/2021
2Breast Neoplasms (Breast Cancer)
03/2024 - 01/2021
2Colitis
02/2024 - 01/2021
2Stomach Neoplasms (Stomach Cancer)
01/2024 - 01/2021
2Pain (Aches)
01/2024 - 01/2020
2Atrophy
10/2023 - 01/2022
2Cognitive Dysfunction
10/2023 - 01/2022
2Chronic Renal Insufficiency
04/2023 - 01/2022
2Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2021
2Heart Failure
01/2022 - 01/2021
2Peripheral Nervous System Diseases (PNS Diseases)
01/2020 - 01/2020
1Keratosis
04/2024
1Drug-Related Side Effects and Adverse Reactions
03/2024
1Ulcerative Colitis
02/2024
1Body Weight (Weight, Body)
02/2024
1Cancer Pain
01/2024
1Alzheimer Disease (Alzheimer's Disease)
10/2023
1Sarcopenia
10/2023
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
10/2023
1Hypoxia (Hypoxemia)
04/2023
1Familial paroxysmal dystonia
01/2023
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2023
1Epilepsy (Aura)
01/2023
1Sarcoma (Soft Tissue Sarcoma)
01/2023
1Seizures (Absence Seizure)
01/2023
1Lewis Lung Carcinoma
02/2022
1Myocardial Infarction
01/2021
1Autoimmune Diseases (Autoimmune Disease)
01/2021
1Ovarian Neoplasms (Ovarian Cancer)
01/2021
1Hepatocellular Carcinoma (Hepatoma)
01/2021

Drug/Important Bio-Agent (IBA)

3artenimol (dihydroartemisinin)IBA
04/2024 - 01/2022
3artemisinin (artemisinine)IBA
04/2024 - 01/2022
3Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2022
2Therapeutic UsesIBA
10/2023 - 02/2023
2IronIBA
04/2023 - 01/2023
2Immune Checkpoint InhibitorsIBA
03/2023 - 02/2023
2ChemokinesIBA
01/2023 - 01/2021
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2022
2CanagliflozinIBA
01/2022 - 01/2021
2NAD (NADH)IBA
01/2020 - 01/2020
1Receptor Tyrosine Kinase-like Orphan ReceptorsIBA
04/2024
1upadacitinibIBA
04/2024
1Glutamine (L-Glutamine)FDA Link
03/2024
1gegenqinlianIBA
02/2024
1Eosine Yellowish-(YS) (Eosin)IBA
02/2024
1Transcription Factors (Transcription Factor)IBA
02/2024
1Hematoxylin (Haematoxylon)IBA
02/2024
1NLR ProteinsIBA
02/2024
1InflammasomesIBA
02/2024
1ChromatinIBA
10/2023
1HeterochromatinIBA
10/2023
1Pemetrexed (MTA)FDA Link
10/2023
1tongluoIBA
10/2023
1Branched-Chain Amino AcidsIBA
10/2023
1HematinicsIBA
04/2023
1C-Reactive ProteinIBA
04/2023
1Prolyl-Hydroxylase InhibitorsIBA
04/2023
1roxadustatIBA
04/2023
1Tyrosine Kinase InhibitorsIBA
03/2023
1Antigen-Antibody Complex (Immune Complex)IBA
01/2023
1Anaplastic Lymphoma KinaseIBA
01/2023
1CytokinesIBA
01/2023
1Chemokine ReceptorsIBA
01/2023
1HMGB1 Protein (HMG1)IBA
01/2023
1ErbB Receptors (EGF Receptor)IBA
01/2023
1docosahexaenoylascorbic acid (DHA-As)IBA
02/2022
1CreatinineIBA
01/2022
1ApolipoproteinsIBA
01/2022
1Oxygen (Dioxygen)IBA
01/2022
1empagliflozinIBA
01/2022
1(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA
01/2022
1ArtesunateIBA
01/2022
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2022
1dapagliflozinIBA
01/2022
1SymportersIBA
01/2022
1Apolipoproteins E (ApoE)IBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1SodiumIBA
01/2022
1ertugliflozinIBA
01/2022
1Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021
1AgarIBA
02/2021
1AntigensIBA
01/2021
1AutoantibodiesIBA
01/2021
1PlatinumIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Sulfonic AcidsIBA
01/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021
1phenazineFDA Link
01/2021

Therapy/Procedure

7Therapeutics
03/2024 - 01/2021
4Immunotherapy
01/2024 - 01/2022
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2024
1Acupuncture Points (Acupuncture Point)
01/2024
1Moxibustion
10/2023
1Drug Therapy (Chemotherapy)
01/2021